CLDI icon

Calidi Biotherapeutics
CLDI

Overview Fund Activity

26 hedge funds and large institutions have $40.6M invested in Calidi Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
4
Reduced
3
Closed
2
Calls
$622K
Puts
–
Net Calls
+$622K
Net Calls Change
+$6K

Top Buyers

1
GCL
1
Glazer Capital LLC
New York
$3.85M
2
Deutsche Bank
2
Deutsche Bank
Germany
$1.43M
3
CSS
3
Cubist Systematic Strategies
Connecticut
$2.08M
4
CCM
4
CAAS Capital Management
New York
$201K
5
PCM
5
PenderFund Capital Management
British Columbia, Canada
$921K

Top Sellers

1
FTCM
1
First Trust Capital Management
Illinois
$0
2
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$2.03M
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
E
4
Ergoteles
New York
$196K
5
EC
5
Elequin Capital
New York
$1.74M
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
26
Clear Street
New York
$11.2K +$9.95K +8 +800%
UBS Group
27
UBS Group
Switzerland
$113 -$244 – –
FTCM
28
First Trust Capital Management
Illinois
– -$4.07M -3,333 Closed
Citadel Advisors
29
Citadel Advisors
Florida
– -$954K -782 Closed
1
2